Jason Bassetti
Lawyers
Filters
NeoGenomics $230 million stock and $345 million convertible notes offerings
We advised the joint book-running managers on the public offerings of stock and convertible notes
Mirion Technologies acquisition of Sun Nuclear and related financing
We advised Mirion on the acquisition and incremental term loan credit facility
Ultra Clean Holdings purchase of Ham-Let (Israel-Canada) and related financing
Davis Polk is advising Ultra Clean Holdings, Inc. on its acquisition of Ham-Let (Israel-Canada) Ltd. for approximately $348 million, which includes $287 million of equity value plus $61…
Seer $336 million IPO and concurrent private placement
Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 10,592,106 shares of Class A common stock of Seer, Inc. at $19.00 per…
BeiGene $340 million secondary offering
Davis Polk advised the underwriter in connection with the $340 million SEC-registered offering of 1,511,546 American depositary shares of BeiGene, Ltd. by certain existing ADS holders. The…
Marcus $100.05 million convertible senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by The Marcus Corporation of $100.05 million aggregate principal amount of its 5…
Acutus Medical $170 million IPO
Davis Polk advised Acutus Medical, Inc. on its SEC-registered initial public offering of 10,147,058 shares of common stock for an aggregate price to the public of approximately $170 million…
Alphabet $10 billion notes offering
Davis Polk advised the joint book-running managers on an SEC-registered debt offering by Alphabet Inc., consisting of $1 billion of 0.450% notes due 2025, $1 billion of 0.800% notes…
CryoLife $100 million convertible senior notes offering
Davis Polk advised the initial purchaser in connection with a Rule 144A offering by CryoLife, Inc. of $100 million aggregate principal amount of its 4.250% convertible senior notes due 2025…
Shockwave Medical $89.4 million stock offering
Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 1,955,000 shares of common stock for an aggregate price to the public of approximately $89.4 million,…